Cancer Institute of NJ, UW Carbone Reap $4.3M for Genomic Medicine Trial | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the
Rutgers Cancer Institute of New Jersey (CINJ) and the University of Wisconsin Carbone Cancer Center have won a $4.3 million grant from the National Cancer Institute to conduct a clinical trial seeking to identify and use genomic biomarkers to provide targeted cancer treatments, CINJ said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.